144 related articles for article (PubMed ID: 1547777)
1. An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.
Konvalinka J; Horejsí M; Andreánsky M; Novek P; Pichová I; Bláha I; Fábry M; Sedlácek J; Foundling S; Strop P
EMBO J; 1992 Mar; 11(3):1141-4. PubMed ID: 1547777
[TBL] [Abstract][Full Text] [Related]
2. Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus.
Sedlacek J; Fabry M; Coward JE; Horejsi M; Strop P; Luftig RB
Virology; 1993 Feb; 192(2):667-72. PubMed ID: 7678476
[TBL] [Abstract][Full Text] [Related]
3. Specificity studies on retroviral proteinase from myeloblastosis-associated virus.
Strop P; Konvalinka J; Stys D; Pavlickova L; Blaha I; Velek J; Travnicek M; Kostka V; Sedlacek J
Biochemistry; 1991 Apr; 30(14):3437-43. PubMed ID: 1849425
[TBL] [Abstract][Full Text] [Related]
4. Subsite specificity of the proteinase from myeloblastosis associated virus.
Konvalinka J; Blaha I; Skrabana R; Sedlacek J; Pichova I; Kapralek F; Kostka V; Strop P
FEBS Lett; 1991 Apr; 282(1):73-6. PubMed ID: 2026269
[TBL] [Abstract][Full Text] [Related]
5. Effect of substrate residues on the P2' preference of retroviral proteinases.
Boross P; Bagossi P; Copeland TD; Oroszlan S; Louis JM; Tözsér J
Eur J Biochem; 1999 Sep; 264(3):921-9. PubMed ID: 10491141
[TBL] [Abstract][Full Text] [Related]
6. Protein-engineered proteinase of myeloblastosis associated virus, an enzyme of high activity and HIV-1 proteinase-like specificity.
Strop P; Horejsí M; Konvalinka J; Skrabana R; Velek J; Bláha I; Cerná V; Pichová I; Pavlícková L; Andreánsky M
Adv Exp Med Biol; 1991; 306():515-8. PubMed ID: 1812751
[No Abstract] [Full Text] [Related]
7. 15gag proteinase of myeloblastosis-associated virus: specificity studies with substrate-based inhibitors.
Pavlícková L; Stys D; Soucek M; Urban J; Hrusková O; Sedlácek J; Strop P
Arch Biochem Biophys; 1992 Nov; 298(2):753-6. PubMed ID: 1417001
[TBL] [Abstract][Full Text] [Related]
8. Molecular model of equine infectious anemia virus proteinase and kinetic measurements for peptide substrates with single amino acid substitutions.
Weber IT; Tözsér J; Wu J; Friedman D; Oroszlan S
Biochemistry; 1993 Apr; 32(13):3354-62. PubMed ID: 8384880
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of vimentin by different retroviral proteases.
Snásel J; Shoeman R; Horejsí M; Hrusková-Heidingsfeldová O; Sedlácek J; Ruml T; Pichová I
Arch Biochem Biophys; 2000 May; 377(2):241-5. PubMed ID: 10845700
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of retroviral proteases.
Fitzgerald PM; Springer JP
Annu Rev Biophys Biophys Chem; 1991; 20():299-320. PubMed ID: 1651087
[No Abstract] [Full Text] [Related]
11. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates.
Grinde B; Cameron CE; Leis J; Weber IT; Wlodawer A; Burstein H; Skalka AM
J Biol Chem; 1992 May; 267(14):9491-8. PubMed ID: 1315756
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases.
Tözsér J; Zahuczky G; Bagossi P; Louis JM; Copeland TD; Oroszlan S; Harrison RW; Weber IT
Eur J Biochem; 2000 Oct; 267(20):6287-95. PubMed ID: 11012683
[TBL] [Abstract][Full Text] [Related]
14. Mutations that alter the activity of the Rous sarcoma virus protease.
Grinde B; Cameron CE; Leis J; Weber IT; Wlodawer A; Burstein H; Bizub D; Skalka AM
J Biol Chem; 1992 May; 267(14):9481-90. PubMed ID: 1315755
[TBL] [Abstract][Full Text] [Related]
15. Structural studies of the retroviral proteinase from avian myeloblastosis associated virus.
Ohlendorf DH; Foundling SI; Wendoloski JJ; Sedlacek J; Strop P; Salemme FR
Proteins; 1992 Nov; 14(3):382-91. PubMed ID: 1332025
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 RT enhances the activity of a tethered dimer of HIV-1 proteinase.
Goobar-Larsson L; Larsson PT; Debouck C; Towler EM
Biochem Biophys Res Commun; 1996 Mar; 220(1):203-7. PubMed ID: 8602845
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW; Cameron CE; Cameron J; Leis J; Copeland T; Wlodawer A; Weber IT; Harrison RW
J Biol Chem; 1996 Mar; 271(9):4709-17. PubMed ID: 8617736
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases.
Konvalinka J; Heuser AM; Hruskova-Heidingsfeldova O; Vogt VM; Sedlacek J; Strop P; Kräusslich HG
Eur J Biochem; 1995 Feb; 228(1):191-8. PubMed ID: 7883003
[TBL] [Abstract][Full Text] [Related]
19. Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.
Strisovsky K; Tessmer U; Langner J; Konvalinka J; Kräusslich HG
Protein Sci; 2000 Sep; 9(9):1631-41. PubMed ID: 11045610
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.
Beck ZQ; Lin YC; Elder JH
J Virol; 2001 Oct; 75(19):9458-69. PubMed ID: 11533208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
